In this age of personalized medicine, it seems obvious that a clinical trial studying a new medicine should include representatives from the entire population to whom it may be prescribed. However, for many of the studies currently being conducted this is not the case.
While globalization has broadened the overall diversity of participation in clinical trials, in the US the patients taking part in clinical trials are not characteristic of the population at large.
In this webinar, you will hear about the important work being done in Dr. Sandoval's clinic to support participation of more patients from ethnic minorities in clinical trials, and how the industry as a whole can work better to provide clinical trial opportunities to a broad patient community.
The webinar is moderated by DrugDev's Claire Sears and concludes with a live Q&A session with Dr. Sandoval.